Rosemarie
Rosemarie Banckwitz, Forchheim DE
Patent application number | Description | Published |
---|---|---|
20110013747 | Method for Operating an X-Ray Image Recording Device Having a Moveable X-Ray Detector on the X-Ray C-Arm - A method for operating an x-ray image recording device having a movable x-ray detector on an-x-ray c-arm is provided. The x-ray C-arm supports an x-ray source and the x-ray detector which can be moved in the direction of the x-ray source. A variable is calculated which specifies the image quality of an x-ray image to be obtained in a position of the x-ray C-arm in a position of the x-ray detector and/or specifies the exposure dose of an operating person. A measure is taken as a function of the variable which results in a movement of the x-ray detector by the operating person and/or by an automatic movement. X-ray images are recorded in positions of the x-ray detector in which the image quality and/or the exposure dose of an operating person are optimal. | 01-20-2011 |
Rosemarie Bolha, Wilkes-Barre, PA US
Patent application number | Description | Published |
---|---|---|
20140172739 | SYSTEM AND METHOD OF COORDINATING DISTRIBUTION OF AN ITEM - A system and method for coordinating item delivery is disclosed. The system includes a control hub configured to receive item information, a dynamic routing system configured to provide routing instructions, and a handheld device configured to receive routing instructions. The control hub controls and coordinates receiving and transmitting item information, including pick-up and delivery schedules, and other item information. | 06-19-2014 |
Rosemarie Bot-Schulz, Gerolzhofen DE
Patent application number | Description | Published |
---|---|---|
20110083374 | BONDED ABRASIVE ARTICLE AND METHOD OF FORMING - An abrasive article having an abrasive body including abrasive grains contained within a bond material, wherein the abrasive grains comprise microcrystalline alumina, and wherein the bond material includes less than about 1.0 mol % phosphorous oxide (P | 04-14-2011 |
20140069021 | Bonded Abrasive Article and Method of Forming - An abrasive article having an abrasive body including abrasive grains contained within a bond material, wherein the abrasive grains comprise microcrystalline alumina, and wherein the bond material includes less than about 1.0 mol % phosphorous oxide (P | 03-13-2014 |
Rosemarie Daig, Regensburg DE
Patent application number | Description | Published |
---|---|---|
20090222938 | Therapeutic Target Molecules For The Development of Novel Medicaments for Degenerative Diseases - The present invention generally relates to the field of therapy, prophylaxis and diagnosis of degenerative diseases, in particular neurodegenerative diseases. Specifically, the present invention relates to genes and proteins, which are regulated in connection with chronic oxidative stress in cells and are applied for therapy, prophylaxis, and diagnosis of degenerative diseases, in particular neurodegenerative diseases. Additionally, the present invention relates to the use of genes and proteins, which are regulated in conjunction with chronic oxidative stress in cells, for the screening of candidate substances to identify prophylactic and/or therapeutic agents, which agents modulate the biologic activity of genes and/or proteins, which genes and/or proteins are activated in conjunction with chronic oxidative stress in cells. Further, the present invention relates to methods for diagnosis of degenerative diseases, in particular neurodegenerative diseases, and methods for identifying prophylactic and/or therapeutic agents, which agents modulate the biologic activity of genes and/or proteins, which genes and/or proteins are activated in conjunction with chronic oxidative stress in cells. Further, the present invention relates to kits performing the methods of diagnosis. | 09-03-2009 |
Rosemarie Dekruyee US
Patent application number | Description | Published |
---|---|---|
20090252737 | T Cell Regulatory Genes And Methods Of Use Thereof - A genetic locus and corresponding family of proteins associated with regulation of immune function and cell survival are provided. These genes encode cell surface molecules with conserved IgV and mucin domains. The locus comprising the TIM family is genetically associated with immune dysfunction, including asthma. Furthermore, the TIM gene family is located within a region of human chromosome 5 that is commonly deleted in malignancies and myelodysplastic syndrome. Polymorphisms in the gene sequences are associated with the development of airway hyperreactivity and allergic inflammation, and T cell production of IL-4 and IL-13. The proteins include the human hepatitis A cellular receptor, hHAVcr-1. | 10-08-2009 |
Rosemarie Dekruyff, Newton, MA US
Patent application number | Description | Published |
---|---|---|
20080241174 | Production And Therapeutic Uses Of Th1-Like Regulatory T Cells - A unique CD4 | 10-02-2008 |
20130202628 | PRODUCTION AND THERAPEUTIC USES OF TH1-LIKE REGULATORY T CELLS - A unique CD4 | 08-08-2013 |
20150023986 | Modulation of Tim Receptor Activity in Combination with Cytoreductive Therapy - A genetic locus and corresponding family of proteins associated with regulation of immune function and cell survival are provided. These genes encode cell surface molecules with conserved IgV and mucin domains. The locus comprising the TIM family is genetically associated with immune dysfunction, including asthma. Furthermore, the TIM gene family is located within a region of human chromosome 5 that is commonly deleted in malignancies and myelodysplastic syndrome. Polymorphisms in the gene sequences are associated with the development of airway hyperreactivity and allergic inflammation, and T cell production of IL-4 and IL-13. The proteins include the human hepatitis A cellular receptor, hHAVcr-1. | 01-22-2015 |
20150299322 | Agents That Modulate Immune Cell Activation and Methods of Use Thereof - The present invention relates to compositions and methods for the immunomodulation mediated by the interaction of PD-L2 and RGMb. | 10-22-2015 |
Rosemarie Dekruyff, Stanford, CA US
Patent application number | Description | Published |
---|---|---|
20120156224 | MODULATION OF TIM RECEPTOR ACTIVITY IN COMBINATION WITH CYTOREDUCTIVE THERAPY - A genetic locus and corresponding family of proteins associated with regulation of immune function and cell survival are provided. These genes encode cell surface molecules with conserved IgV and mucin domains. The locus comprising the TIM family is genetically associated with immune dysfunction, including asthma. Furthermore, the TIM gene family is located within a region of human chromosome 5 that is commonly deleted in malignancies and myelodysplastic syndrome. Polymorphisms in the gene sequences are associated with the development of airway hyperreactivity and allergic inflammation, and T cell production of IL-4 and IL-13. The proteins include the human hepatitis A cellular receptor, hHAVcr-1. | 06-21-2012 |
Rosemarie Elefante, Loveland, OH US
Patent application number | Description | Published |
---|---|---|
20090149813 | TROCAR SEAL WITH REDUCED CONTACT AREA - Seal assemblies or valves, generally for use in trocar assemblies, are provided for reducing the amount of contact between an instrument being passed into and out of a trocar assembly and an inner surface of a sealing wall of such seal assemblies or valves. In one exemplary embodiment a valve includes an activation extension that is formed on the inner surface of the sealing wall of the valve and is configured such that a distal end of the sealing wall is moved to the open position by an instrument contacting the activation extension. In one embodiment the instrument does not come into contact with the inner surface of the sealing wall during the procedure. In another embodiment a distal-most end of the activation extension can be closer to a longitudinal axis extending through the flange than the inner surface of the sealing wall. | 06-11-2009 |
20110257598 | TROCAR SEAL WITH REDUCED CONTACT AREA - Seal assemblies or valves, generally for use in trocar assemblies, are provided for reducing the amount of contact between an instrument being passed into and out of a trocar assembly and an inner surface of a sealing wall of such seal assemblies or valves. In one exemplary embodiment a valve includes an activation extension that is formed on the inner surface of the sealing wall of the valve and is configured such that a distal end of the sealing wall is moved to the open position by an instrument contacting the activation extension. In one embodiment the instrument does not come into contact with the inner surface of the sealing wall during the procedure. In another embodiment a distal-most end of the activation extension can be closer to a longitudinal axis extending through the flange than the inner surface of the sealing wall. | 10-20-2011 |
Rosemarie Hederer, Cambridge GB
Patent application number | Description | Published |
---|---|---|
20120149591 | IN VITRO PEPTIDE EXPRESSION LIBRARY - The invention provides a method for making in vitro peptide expression libraries, and for the isolation of nucleotide sequences encoding peptides of interest, wherein the peptides or proteins are specifically associated with the DNA encoding them through non-covalent protein:DNA binding. The method describes ways of making the library itself, DNA molecules encoding the library and uses of the expression library. | 06-14-2012 |
Rosemarie Helmerich, Berlin DE
Patent application number | Description | Published |
---|---|---|
20110088472 | DEVICE AND METHOD FOR THE DETECTION OF COMPOSITE DEFECTS - Provided is a method for detecting composite defects between a first material and a second material, comprising the steps of: (a) introducing horizontally polarized low-frequency transverse waves into an upper surface of the composite material; (b) detecting an ultrasound echo of the emitted low-frequency horizontally polarized transverse waves; (c) displaying the detected ultrasound echoes on a display device. | 04-21-2011 |
Rosemarie Immesberger, Otterberg DE
Patent application number | Description | Published |
---|---|---|
20110209619 | FILTER MEDIUM FOR PARTICULATE FILTRATION - A filter medium comprising a carrier layer ( | 09-01-2011 |
Rosemarie Keikert, Neuwied DE
Patent application number | Description | Published |
---|---|---|
20150320676 | TOPICAL DRUG FOR TREATING APHTHAE - Topical drugs for treating aphthae, wherein the topical drugs are in the form of a film-shaped dosage form. The topical drugs include a film made of a water-swellable or water-soluble polymer or polymer mixture, and at least one active ingredient selected from the group of tanning agents and essential oils. | 11-12-2015 |
Rosemarie Kientsch-Engel, Feldafing DE
Patent application number | Description | Published |
---|---|---|
20100159491 | H-FABP AS EARLY PREDICTOR OF MYOCARDIAL INFARCTION - The present invention relates to a method for diagnosing myocardial infarction in a subject who suffers from acute coronary syndrome and has a cardiac troponin level which is detectable but lower than the level that is considered as being indicative for a myocardial infarction. Moreover, the present invention relates to a method for identifying a subject being susceptible to cardiac intervention, wherein the subject suffers from acute coronary syndrome and has a cardiac troponin level which is detectable but lower than a level that is considered as being indicative for a myocardial infarction. The methods of the present invention are based on the determination of H-FABP and, optionally, myoglobin in a sample of the subject and comparing the amount of H-FABP and, optionally, myoglobin to reference amounts. | 06-24-2010 |
20100285595 | MYOGLOBIN AS EARLY PREDICTOR OF MYOCARDIAL INFARCTION - The present invention relates to a method for diagnosing myocardial infarction in a subject who suffers from acute coronary syndrome and has a cardiac troponin level, which is detectable, but lower than the level that is considered as being indicative for a myocardial infarction. Moreover, the present invention relates to a method for identifying a subject being susceptible to cardiac intervention, wherein the subject suffers from acute coronary syndrome and has a cardiac troponin level which is detectable, but lower than a level that is considered as being indicative for a myocardial infarction. The methods of the present invention are based on the determination of myoglobin and, optionally, Heart-type fatty acid binding protein (H-FABP) in a sample of said subject and comparing the amount of myoglobin and, optionally, H-FABP to reference amounts. Also comprised by the present invention are kits or devices to carry out the methods of the present invention. | 11-11-2010 |
20140187652 | L-FABP BASED DIAGNOSIS OF KIDNEY INJURY AFTER AN ACUTE EVENT OR AFTER A SURGICAL INTERVENTION - Systems and methods for diagnosing acute kidney injury following an acute event or surgical intervention, based on assessing the biomarker L-FABP. Also, systems and methods for predicting the risk of an individual to suffer from a kidney injury after an acute event or surgical intervention in the future. | 07-03-2014 |
Rosemarie Lembo James, Stuart, FL US
Patent application number | Description | Published |
---|---|---|
20120278974 | Shoulder Strap Retainer For Garments - The present invention relates to a shoulder strap retainer for garments, and more particularly to an undergarment strap retention device for retaining a shoulder strap of an undergarment beneath a shoulder strap of an outer garment. Retention of a strap of an undergarment, such as a bra, beneath the shoulder strap of an outer garment is accomplished by a pair of members which are magnetically attracted to each other. One of the members, an anchor assembly, is secured to a strap of an undergarment. The strap of the outer garment is positioned above and adjacent to the undergarment with the inner strap hidden from view. A decorative base plate is placed against the outer surface of the outer garment to engage the magnetic field produced by magnets positioned within the anchor assembly so the magnetic field pulls against the base plate to sandwich the cloth of the outer garment. | 11-08-2012 |
Rosemarie Lichtner, Berlin DE
Patent application number | Description | Published |
---|---|---|
20100168179 | 6-ALKENYL-, 6-ALKINYL- AND 6-EPOXY-EPOTHILONE DERIVATIVES, PROCESS FOR THEIR PRODUCTION, AND THEIR USE IN PHARMACEUTICAL PREPARATIONS - This invention describes the new 6-alkenyl- and 6-alkinyl-epothilone derivatives of general formula (I) in which R | 07-01-2010 |
Rosemarie Scafa, Mill Valley, CA US
Patent application number | Description | Published |
---|---|---|
20080208968 | SYSTEM AND METHOD FOR AUTOMATED DOCUMENTATION FOR SOLICITED TRADES - A system and method are provided that allow for automated documentation of all advice interactions between broker representatives on one end and clients, or prospective clients, on the other. This is accomplished by providing a computer system for storing appropriate data for each advice interaction with a client. The advice interaction data can be used to assess compliance with existing regulations, as well as for analytical and training purposes. | 08-28-2008 |
Rosemarie Sift, Freiburg-Tiengen DE
Patent application number | Description | Published |
---|---|---|
20100108994 | ELECTROLUMINESCENT METAL COMPLEXES WITH BENZOTRIAZOLES - This invention relates to electroluminescent metal complexes with benzotriazoles of the formula (I), a process for their preparation, electronic devices comprising the metal complexes and their use in electronic devices, especially organic light emitting diodes (OLEDs), as oxygen sensitive indicators, as phosphorescent indicators in bioassays, and as catalysts. | 05-06-2010 |
Rosemarie Sift Carter, Basel CH
Patent application number | Description | Published |
---|---|---|
20080255223 | Treatment and Prevention of Benign Pigmented Moles (Naevi) Using Artemisinine and the Derivatives Thereof - A method of treating a benign pigmented mole or a dermatomycosis. The method comprises locally applying to a subject in need thereof artemisinine and/or one or more structurally related compounds. Also disclosed is a plaster which comprises a topical formulation comprising artemisinine and/or one or more structurally related compounds. | 10-16-2008 |
20120022150 | TREATMENT AND PREVENTION OF BENIGN PIGMENTED MOLES (NAEVI) USING ARTEMISININE AND THE DERIVATIVES THEREOF - A method of treating a benign pigmented mole or a dermatomycosis. The method comprises locally applying to a subject in need thereof artemisinine and/or one or more structurally related compounds. Also disclosed is a plaster which comprises a topical formulation comprising artemisinine and/or one or more structurally related compounds. | 01-26-2012 |
Rosemarie Torla, Bellmore, NY US
Rosemarie Waiand, Jersey Village, TX US
Patent application number | Description | Published |
---|---|---|
20140067693 | TECHNOLOGY TRANSITION FRAMEWORK - A method for deploying a product through multiple phases includes defining work streams for deploying the product, where each work stream is defined for a set of components of a client environment. For each work stream and for each phase, a set of predefined tasks are identified for the phase, a computer processor gathers for the phase a set of instruments specific to the work stream for performing the set of predefined tasks, and the set of instruments are stored in a data repository of a deployment framework. The set of predefined tasks for the phase is common amongst the work streams. | 03-06-2014 |
Rosemarie Weber, Edenbergen DE
Patent application number | Description | Published |
---|---|---|
20160060463 | Pastes Containing Solvent - The invention relates to paste preparations containing 0.5-30% w/w chemically unmodified rice bran wax, —0.5-30% w/w paraffin wax, selected from the group of macrocrystalline and microcrystalline paraffins and Fischer-Tropsch paraffins, —optionally up to a maximum of 10% w/w polyethylene wax, —optionally up to a maximum of 10% w/w native or chemically modified recent or fossil vegetable waxes and—organic solvents to make up to 100% w/w. | 03-03-2016 |